|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.20 CNY | +1.64% |
|
-3.74% | +4.73% |
| 05-30 | Xingqi Pharmaceutical Says No Adverse Effects Seen in Phase 1 Eye Drops Trial | MT |
| 05-26 | Shenyang Xingqi Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 850 million in funding | CI |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1.64% | -3.74% | -6.33% | +3.44% | +4.73% | -60.50% | -4.52% | -1.34% | - | 1.75B | ||
| -0.13% | -0.48% | -0.65% | -14.73% | -18.05% | -33.34% | -30.09% | +14.81% | +25.62% | 57.7B | ||
| +0.26% | +2.55% | +14.89% | +14.60% | +5.07% | -9.15% | -11.55% | -8.40% | +48.57% | 9.05B | ||
| -0.11% | -0.61% | +10.15% | -13.41% | +12.78% | +8.93% | +20.82% | +132.92% | +163.93% | 6.65B | ||
| -0.19% | +2.41% | -0.65% | -14.82% | -11.05% | +42.68% | +116.23% | +150.40% | +221.83% | 5.8B | ||
| +1.77% | +1.66% | +1.32% | -13.79% | -17.28% | +17.37% | +29.25% | - | - | 5.18B | ||
| -2.49% | -1.20% | +26.30% | +22.89% | +14.50% | +63.23% | +14.01% | -47.00% | - | 3.71B | ||
| -0.28% | +0.47% | +3.55% | -6.74% | -9.55% | -1.19% | +20.13% | +19.21% | -60.58% | 2.02B | ||
| +1.37% | -2.05% | -0.03% | +3.87% | -10.20% | +24.93% | +18.37% | +40.75% | +76.76% | 1.79B | ||
| +1.46% | +2.46% | +25.98% | +38.67% | +1.56% | -21.09% | -26.50% | +186.90% | -9.49% | 1.74B | ||
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64B | ||
| +0.48% | +7.23% | +8.16% | +8.29% | +15.16% | +79.78% | -50.96% | - | - | 1.31B | ||
| -0.57% | -0.48% | +31.89% | +19.95% | +22.66% | +14.47% | -5.51% | -60.10% | - | 1.3B | ||
| -0.61% | -0.43% | +0.77% | -10.52% | -16.33% | -33.11% | -55.47% | - | - | 1.22B | ||
| +0.48% | +0.72% | +10.96% | +11.55% | +0.96% | +33.55% | +75.00% | +64.71% | +33.12% | 1.2B | ||
| +15.97% | +36.31% | +38.11% | +34.21% | +38.58% | +12.51% | +6.45% | - | - | 1.07B | ||
| -1.51% | +2.58% | +22.67% | +36.96% | +77.04% | +203.81% | +397.92% | +141.41% | -42.87% | 988M | ||
| +5.26% | +13.71% | +31.78% | +26.87% | +38.21% | +81.82% | +2.72% | -46.71% | -67.68% | 985M | ||
| -0.69% | +5.85% | +5.60% | +19.23% | +21.06% | +21.40% | +5.85% | - | - | 907M | ||
| +0.12% | +2.40% | -4.36% | +47.64% | +31.60% | +1.88% | +145.32% | -33.26% | +261.42% | 892M | ||
| Average | +1.03% | +1.00% | +11.58% | +11.27% | +10.60% | +23.58% | +35.13% | +39.59% | +59.15% | 5.35B | |
| Weighted average by Cap. | +0.02% | -0.03% | +4.45% | -5.85% | -7.64% | -9.84% | -3.02% | +29.91% | +50.19% |
- Stock Market
- Equities
- 300573 Stock
- Sector Shenyang Xingqi Pharmaceutical Co.,Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition